Global 3D Bio-Printers in Medical Market Insights, Forecast to 2025

SKU ID : QYR- 13246947

Publishing Date : 19-Mar-2019

No. of pages : 118

PRICE
4900
9800


  • 3D Bioprinter that uses 3D-printing technology to create complex 3-dimensional structures, which can be built with living cells to create real living tissue.
    The global 3D Bio-Printers in Medical market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the 3D Bio-Printers in Medical market based on company, product type, end user and key regions.

    This report studies the global market size of 3D Bio-Printers in Medical in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of 3D Bio-Printers in Medical in these regions.
    This research report categorizes the global 3D Bio-Printers in Medical market by top players/brands, region, type and end user. This report also studies the global 3D Bio-Printers in Medical market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

    The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    EnvisionTEC
    Biobots
    RegenHU
    Cellink
    Organovo
    3Dynamic Systems
    Poietis
    Regenovo Biotechnology

    Market size by Product
    Magnetic 3D Bioprinting
    Laser-Assisted Bioprinting
    Inkjet 3D Bioprinting
    Microextrusion 3D Bioprinting
    Market size by End User
    Hospitals
    Clinics
    Research Labs
    Others

    Market size by Region
    North America
    United States
    Canada
    Mexico
    Asia-Pacific
    China
    India
    Japan
    South Korea
    Australia
    Indonesia
    Singapore
    Malaysia
    Philippines
    Thailand
    Vietnam
    Europe
    Germany
    France
    UK
    Italy
    Spain
    Russia
    Central & South America
    Brazil
    Rest of Central & South America
    Middle East & Africa
    GCC Countries
    Turkey
    Egypt
    South Africa

    The study objectives of this report are:
    To study and analyze the global 3D Bio-Printers in Medical market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
    To understand the structure of 3D Bio-Printers in Medical market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global 3D Bio-Printers in Medical companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
    To project the value and sales volume of 3D Bio-Printers in Medical submarkets, with respect to key regions.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    In this study, the years considered to estimate the market size of 3D Bio-Printers in Medical are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025

    This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of 3D Bio-Printers in Medical market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.